Literature for eribaxaban (S01.216 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2007
1. Kohrt,J.T., Bigge,C.F., Bryant,J.W., Casimiro-Garcia,A., Chi,L., Cody,W.L., Dahring,T., Dudley,D.A., Filipski,K.J., Haarer,S., Heemstra,R., Janiczek,N., Narasimhan,L., McClanahan,T., Peterson,J.T., Sahasrabudhe,V., Schaum,R., Van Huis,C.A., Welch,K.M., Zhang,E., Leadley,R.J. and Edmunds,J.J.
   The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor
   Chem Biol Drug Des70, 100-112. PubMed  Europe PubMed DOI  I